• Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) Receives Average Rating of "Moderate Buy" from Analysts

    Source: Buzz FX / 22 Feb 2025 01:21:13   America/Chicago


    Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) Receives Average Rating of "Moderate Buy" from Analysts Written by MarketBeat February 22, 2025 Share Link copied to clipboard. Crinetics Pharmaceuticals, Inc.
    Read more...
Share on,